Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 8Stomach Neoplasms 5Colorectal Neoplasms 4Pancreatic Neoplasms 3Pain, Postoperative 3Myoma 3Warts 2Rectal Neoplasms 2Meningioma 2Lung Neoplasms 2Urolithiasis 1Surgery 1Skin Diseases 1Sigmoid Neoplasms 1Sarcoma 1Recurrence 1Radiodermatitis 1Prostatic Neoplasms 1Pneumoperitoneum 1Pharyngitis 1Peripheral Nervous System Diseases 1Ovarian Neoplasms 1Neuroma 1Neuralgia 1Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Multiple Endocrine Neoplasia Type 1 1Melanoma 1Maxillofacial Tumors 1

Interventions

Sodium Chloride 1Lidocaine 1Hyperthermic Intraperitoneal Chemotherapy 1Cystectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Invasive Bladder Cancer × Sodium Chloride × Clear all
NCT02924480 2022-03-09

Lidocaine

CAMC Health System

Phase NA Completed
50 enrolled
Genitourinary

Invasive Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡